QuantumNexis, Subsidiary of Healthcare Triangle Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion

Reuters

2025/10/01

QuantumNexis, Subsidiary of <a href="https://laohu8.com/S/HCTI">Healthcare Triangle</a> Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion

Healthcare Triangle Inc.'s wholly-owned subsidiary, QuantumNexis, has processed over $20 million in end-user revenue through its Ezovion Electronic Medical Record $(EMR)$ platform. The company forecasts this figure will reach $37 million within six months, driven by rapid international expansion and deeper engagement with existing customers. QuantumNexis is also preparing to launch an integrated payment gateway in late 2025, aiming to turn platform activity into recurring revenue and support global scaling throughout 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF87703) on October 01, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2572553644"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2572553644\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2572553644?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-01 20:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572553644","market":"us","top_or_hot":-1,"title":"QuantumNexis, Subsidiary of Healthcare Triangle Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      QuantumNexis, Subsidiary of <a href=\"https://laohu8.com/S/HCTI\">Healthcare Triangle</a> Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Healthcare Triangle Inc.'s wholly-owned subsidiary, QuantumNexis, has processed over $20 million in end-user revenue through its Ezovion Electronic Medical Record <a href=\"https://laohu8.com/S/EMR\">$(EMR)$</a> platform. The company forecasts this figure will reach $37 million within six months, driven by rapid international expansion and deeper engagement with existing customers. QuantumNexis is also preparing to launch an integrated payment gateway in late 2025, aiming to turn platform activity into recurring revenue and support global scaling throughout 2026.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF87703) on October 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>QuantumNexis, Subsidiary of Healthcare Triangle Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuantumNexis, Subsidiary of Healthcare Triangle Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-01 20:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      QuantumNexis, Subsidiary of <a href=\"https://laohu8.com/S/HCTI\">Healthcare Triangle</a> Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Healthcare Triangle Inc.'s wholly-owned subsidiary, QuantumNexis, has processed over $20 million in end-user revenue through its Ezovion Electronic Medical Record <a href=\"https://laohu8.com/S/EMR\">$(EMR)$</a> platform. The company forecasts this figure will reach $37 million within six months, driven by rapid international expansion and deeper engagement with existing customers. QuantumNexis is also preparing to launch an integrated payment gateway in late 2025, aiming to turn platform activity into recurring revenue and support global scaling throughout 2026.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF87703) on October 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HCTI","symbol_name":"Healthcare Triangle, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL2jRQ8t:1","article_id":"2572553644","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572553644","pubTimestamp":1759320129,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"QuantumNexis, Subsidiary of Healthcare Triangle Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion. Healthcare Triangle Inc.'s wholly-owned subsidiary, QuantumNexis, has processed over $20 million in end-user revenue through its Ezovion Electronic Medical Record  platform. The company forecasts this figure will reach $37 million within six months, driven by rapid international expansion and deeper engagement with existing customers. QuantumNexis is also preparing to launch an integrated payment gateway in late 2025, aiming to turn platform activity into recurring revenue and support global scaling throughout 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the ori","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HCTI":"Healthcare Triangle, Inc.","BK4167":"医疗保健技术"},"translate_title":"Healthcare Triangle Inc.的子公司QuantumNexis在Ezovion平台上的收入超过2000万美元，全球扩张计划达到3700万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCTI":0.9},"content_text":"QuantumNexis, Subsidiary of Healthcare Triangle Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion\n    \n\n        Healthcare Triangle Inc.'s wholly-owned subsidiary, QuantumNexis, has processed over $20 million in end-user revenue through its Ezovion Electronic Medical Record $(EMR)$ platform. The company forecasts this figure will reach $37 million within six months, driven by rapid international expansion and deeper engagement with existing customers. QuantumNexis is also preparing to launch an integrated payment gateway in late 2025, aiming to turn platform activity into recurring revenue and support global scaling throughout 2026.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF87703) on October 01, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}